Big biotech Amgen beat Wall Street’s Q3 estimates and offered mixed guidance late Wednesday, sending the stock up modestly in after-hours trading. Amgen (AMGN) reported adjusted earnings of $2.72 a share, up 18% from a year earlier and beating analysts’ consensus by 34 cents, according to Thomson Reuters. Revenue climbed 14% to $5.72 billion, about $400 million above consensus and the best gain in several years. Amgen lifted its
Apple (AAPL) stock rose in late trading Tuesday after the iPhone maker beat Wall Street’s targets for September-quarter sales and earnings. Apple’s usually conservative guidance forecast sales that were slightly below what analysts have expected. For the quarter ended Sept. 26, Apple earned $1.96 a share on sales of $51.5 billion. Analysts polled by Thomson Reuters expected Apple to earn $1.88 a share on sales of $51.11 billion.
If you’re not buying goods via e-commerce leader Amazon.com, you’re in an ever-shrinking population. Amazon.com (AMZN) stock hurtled to an all-time high Friday after the e-commerce juggernaut’s Q3 earnings late Thursday beat analyst views, with the bottom line swinging to an unexpected profit despite the company’s continued heavy spending on growth. Revenue rose 23% year over year, matching the company’s biggest growth in two